Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Spinal cord glioneuronal tumor with neuropil-like islands with 1p/19q deletion in an adult with low-grade cerebral oligodendroglioma.

Fraum TJ, Barak S, Pack S, Lonser RR, Fine HA, Quezado M, Iwamoto FM.

J Neurooncol. 2012 Apr;107(2):421-6. doi: 10.1007/s11060-011-0760-9. Epub 2011 Nov 15.

PMID:
22083647
2.

Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis.

Barbashina V, Salazar P, Ladanyi M, Rosenblum MK, Edgar MA.

Am J Surg Pathol. 2007 Aug;31(8):1196-202.

PMID:
17667543
3.

[Glioneuronal tumor with neuropil-like island: report of four cases and review of literature].

Duan ZJ, Yao K, Qi XL.

Zhonghua Bing Li Xue Za Zhi. 2016 May 8;45(5):324-8. doi: 10.3760/cma.j.issn.0529-5807.2016.05.008. Review. Chinese.

PMID:
27142914
4.

Disseminated glioneuronal tumor with neuropil-like islands of the spinal cord: a distinctive entity.

Serra SM, Dabdoub CB, da Cunha AH, Salazar B, Lima TP, Azevedo-Filho HC.

World Neurosurg. 2013 Nov;80(5):655.e1-5. doi: 10.1016/j.wneu.2013.02.029. Epub 2013 Feb 9. Review.

PMID:
23403348
5.

Spinal cord oligodendroglioma with 1p and 19q deletions presenting with cerebral oligodendrogliomatosis.

Guppy KH, Akins PT, Moes GS, Prados MD.

J Neurosurg Spine. 2009 Jun;10(6):557-63. doi: 10.3171/2009.2.SPINE08853.

PMID:
19558288
6.

Chromosome 1p and 19q deletions in malignant glioneuronal tumors with oligodendroglioma-like component.

Takeuchi H, Kubota T, Kitai R, Matsuda K, Hashimoto N, Sato K.

J Neurooncol. 2009 Jan;91(1):33-8. doi: 10.1007/s11060-008-9690-6. Epub 2008 Sep 10.

PMID:
18781279
7.

Spinal cord anaplastic oligodendroglioma with 1p deletion: report of a relapsing case treated with temozolomide.

Wang F, Qiao G, Lou X.

J Neurooncol. 2011 Aug;104(1):387-94. doi: 10.1007/s11060-010-0493-1. Epub 2010 Dec 29.

PMID:
21190059
10.

Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.

Singh VY, Chacko G, Chacko AG, Rajshekhar V.

Neurol India. 2014 Jan-Feb;62(1):32-6. doi: 10.4103/0028-3886.128275. Erratum in: Neurol India. 2014 Mar-Apr;62(2):191.

11.

Chromosome 1p/19q status combined with expression of p53 protein improves the diagnostic and prognostic evaluation of oligodendrogliomas.

Xiong J, Liu Y, Wang Y, Ke RH, Mao Y, Ye ZR.

Chin Med J (Engl). 2010 Dec;123(24):3566-73.

PMID:
22166632
12.

Anaplastic oligodendroglioma arising from the brain stem and featuring 1p/19q co-deletion.

Hewer E, Beck J, Vassella E, Vajtai I.

Neuropathology. 2014 Feb;34(1):32-8. doi: 10.1111/neup.12043. Epub 2013 May 27.

PMID:
23711170
13.

Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics.

Perry A, Fuller CE, Banerjee R, Brat DJ, Scheithauer BW.

Front Biosci. 2003 Jan 1;8:a1-9.

PMID:
12456321
14.

[Loss of heterozygosity of chromosome 1p/19q and p53 protein expression in oligodendroglioma].

Xiong J, Liu Y, Li C, Zhu JJ, Ye ZR, Mao Y, Wang Y.

Zhonghua Bing Li Xue Za Zhi. 2009 Jul;38(7):445-50. Chinese.

PMID:
19781190
15.

High rate of deletion of chromosomes 1p and 19q in insular oligodendroglial tumors.

Wu A, Aldape K, Lang FF.

J Neurooncol. 2010 Aug;99(1):57-64. doi: 10.1007/s11060-009-0100-5. Epub 2009 Dec 25.

16.

Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis?

Fellah S, Caudal D, De Paula AM, Dory-Lautrec P, Figarella-Branger D, Chinot O, Metellus P, Cozzone PJ, Confort-Gouny S, Ghattas B, Callot V, Girard N.

AJNR Am J Neuroradiol. 2013 Jul;34(7):1326-33. doi: 10.3174/ajnr.A3352. Epub 2012 Dec 6.

17.

Fluorescent in situ hybridization on isolated tumor cell nuclei: a sensitive method for 1p and 19q deletion analysis in paraffin-embedded oligodendroglial tumor specimens.

Gelpi E, Ambros IM, Birner P, Luegmayr A, Drlicek M, Fischer I, Kleinert R, Maier H, Huemer M, Gatterbauer B, Anton J, Rössler K, Budka H, Ambros PF, Hainfellner JA.

Mod Pathol. 2003 Jul;16(7):708-15.

18.

Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas.

Lin AL, Liu J, Evans J, Leuthardt EC, Rich KM, Dacey RG, Dowling JL, Kim AH, Zipfel GJ, Grubb RL, Huang J, Robinson CG, Simpson JR, Linette GP, Chicoine MR, Tran DD.

Neuro Oncol. 2014 Jan;16(1):123-30. doi: 10.1093/neuonc/not142. Epub 2013 Nov 26.

19.

Combined 1p/19q loss in oligodendroglial tumors: predictive or prognostic biomarker?

Weller M, Berger H, Hartmann C, Schramm J, Westphal M, Simon M, Goldbrunner R, Krex D, Steinbach JP, Ostertag CB, Loeffler M, Pietsch T, von Deimling A; German Glioma Network..

Clin Cancer Res. 2007 Dec 1;13(23):6933-7.

20.

Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.

Reyes-Botero G, Dehais C, Idbaih A, Martin-Duverneuil N, Lahutte M, Carpentier C, Letouzé E, Chinot O, Loiseau H, Honnorat J, Ramirez C, Moyal E, Figarella-Branger D, Ducray F; POLA Network..

Neuro Oncol. 2014 May;16(5):662-70. doi: 10.1093/neuonc/not235. Epub 2013 Dec 18.

Supplemental Content

Support Center